Literature DB >> 9629870

Neuropharmacology of emesis and its relevance to anti-emetic therapy. Consensus and controversies.

P L Andrews1, R J Naylor, R A Joss.   

Abstract

Recent great advances in the neuropharmacology of the emetic pathways have led to better therapy and improved insight into pathophysiological processes in patients undergoing chemo- and radiotherapy. This article gives an overview of the area, outlines current controversies and makes recommendations for future clinical studies.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9629870     DOI: 10.1007/s005200050154

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  10 in total

1.  Relationships of endocrine cells to each other and to other cell types in the human gastric fundus and corpus.

Authors:  Josiane Fakhry; Martin J Stebbing; Billie Hunne; Yulia Bayguinov; Sean M Ward; Kent C Sasse; Brid Callaghan; Rachel M McQuade; John B Furness
Journal:  Cell Tissue Res       Date:  2018-11-22       Impact factor: 5.249

Review 2.  Anti-emetics for cancer chemotherapy-induced emesis: Potential of alternative delivery systems.

Authors:  L Kraut; A A Fauser
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Δ9-THC and related cannabinoids suppress substance P- induced neurokinin NK1-receptor-mediated vomiting via activation of cannabinoid CB1 receptor.

Authors:  Nissar A Darmani; Louiza Belkacemi; Weixia Zhong
Journal:  Eur J Pharmacol       Date:  2019-11-15       Impact factor: 4.432

4.  Cisplatin increases the number of enterochromaffin cells containing substance P in rat intestine.

Authors:  Yusuke Obara; Takuji Machida; Yuho Takano; Saki Shiga; Asami Suzuki; Naoya Hamaue; Kenji Iizuka; Masahiko Hirafuji
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-05-15       Impact factor: 3.000

Review 5.  Mechanisms underlying postoperative nausea and vomiting and neurotransmitter receptor antagonist-based pharmacotherapy.

Authors:  Tong J Gan
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

6.  Controlled release tablet formulation containing natural Δ(9)-tetrahydrocannabinol.

Authors:  Nagendra S Punyamurthula; Tushar Hingorani; Goutham Adelli; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  Drug Dev Ind Pharm       Date:  2015-12-07       Impact factor: 3.225

Review 7.  The emerging role of cannabinoid neuromodulators in symptom management.

Authors:  Mellar Davis; Vincent Maida; Paul Daeninck; Joseph Pergolizzi
Journal:  Support Care Cancer       Date:  2006-12-01       Impact factor: 3.359

8.  Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant.

Authors:  Ian N Olver
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

9.  A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting.

Authors:  Mark A Ware; Paul Daeninck; Vincent Maida
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

10.  [Curative Effect of Aprepitant Preventing CINV].

Authors:  Shasha Guan; Lisha Zhang; Diansheng Zhong; Qing Ma; Fanlu Meng; Yi Shao; Tao Yu; Xia Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-10-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.